BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31484533)

  • 41. High-level expression of periostin is significantly correlated with tumour angiogenesis and poor prognosis in osteosarcoma.
    Hu F; Shang XF; Wang W; Jiang W; Fang C; Tan D; Zhou HC
    Int J Exp Pathol; 2016 Feb; 97(1):86-92. PubMed ID: 27028305
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vascular endothelial growth factor expression in osteosarcoma.
    Charity RM; Foukas AF; Deshmukh NS; Grimer RJ
    Clin Orthop Relat Res; 2006 Jul; 448():193-8. PubMed ID: 16826116
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic value of tumor suppressors in osteosarcoma before and after neoadjuvant chemotherapy.
    Robl B; Pauli C; Botter SM; Bode-Lesniewska B; Fuchs B
    BMC Cancer; 2015 May; 15():379. PubMed ID: 25956431
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of CD133 protein in osteosarcoma and its relationship with the clinicopathological features and prognosis.
    Xie Y; Huang J; Wu M; Zhou Y
    J Cancer Res Ther; 2018; 14(4):892-895. PubMed ID: 29970672
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combined over-expression of the hypoxia-inducible factor 2α gene and its long non-coding RNA predicts unfavorable prognosis of patients with osteosarcoma.
    Li W; He X; Xue R; Zhang Y; Zhang X; Lu J; Zhang Z; Xue L
    Pathol Res Pract; 2016 Oct; 212(10):861-866. PubMed ID: 27623205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does the degree of intratumoural microvessel density and VEGF expression have prognostic significance in osteosarcoma?
    Ek ET; Ojaimi J; Kitagawa Y; Choong PF
    Oncol Rep; 2006 Jul; 16(1):17-23. PubMed ID: 16786118
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.
    Nada OH; Ahmed NS; Abou Gabal HH
    Diagn Pathol; 2014 Mar; 9():72. PubMed ID: 24667142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
    Wang G; Shen N; Cheng L; Lin J; Li K
    Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TfR1 binding with H-ferritin nanocarrier achieves prognostic diagnosis and enhances the therapeutic efficacy in clinical gastric cancer.
    Cheng X; Fan K; Wang L; Ying X; Sanders AJ; Guo T; Xing X; Zhou M; Du H; Hu Y; Ding H; Li Z; Wen X; Jiang W; Yan X; Ji J
    Cell Death Dis; 2020 Feb; 11(2):92. PubMed ID: 32024821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical Significance of G Protein-Coupled Receptor 110 (GPR110) as a Novel Prognostic Biomarker in Osteosarcoma.
    Liu Z; Zhang G; Zhao C; Li J
    Med Sci Monit; 2018 Jul; 24():5216-5224. PubMed ID: 30052620
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aberrant expression of the human epidermal growth factor receptor 2 oncogene is not a common feature in osteosarcoma.
    Baumhoer D; Smida J; Specht K; Bink K; Quintanilla-Martinez L; Rosemann M; Siggelkow H; Nathrath WB; Atkinson MJ; Bielack S; Jundt G; Nathrath M
    Hum Pathol; 2011 Jun; 42(6):859-66. PubMed ID: 21292304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Difference in pre- and postchemotherapy vascular endothelial growth factor levels as a prognostic indicator in osteosarcoma.
    Qu Y; Xu J; Jiang T; Zhao H; Gao Y; Zheng C; Shi X
    J Int Med Res; 2011; 39(4):1474-82. PubMed ID: 21986150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of silencing HIF-1alpha by RNA interference on expression of vascular endothelial growth factor in osteosarcoma cell line SaOS-2 under hypoxia].
    Wu Q; Yang SH; Wang RY; Ye SN; Xia T; Ma DZ
    Ai Zheng; 2005 May; 24(5):531-5. PubMed ID: 15890092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma.
    Chen Z; Liu J; Zhang Y
    Med Sci Monit; 2017 Aug; 23():3861-3868. PubMed ID: 28794404
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.
    Onda M; Matsuda S; Higaki S; Iijima T; Fukushima J; Yokokura A; Kojima T; Horiuchi H; Kurokawa T; Yamamoto T
    Cancer; 1996 Jan; 77(1):71-8. PubMed ID: 8630943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comment on Xu XW et al.: Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
    He S; Xiao Z; Chen L; Xiong S
    Tumour Biol; 2014 Jul; 35(7):6193-4. PubMed ID: 24852425
    [No Abstract]   [Full Text] [Related]  

  • 59. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
    Li RZ; Wang LM
    World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma.
    Lammli J; Fan M; Rosenthal HG; Patni M; Rinehart E; Vergara G; Ablah E; Wooley PH; Lucas G; Yang SY
    Int Orthop; 2012 Nov; 36(11):2307-13. PubMed ID: 22855059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.